takeaway ole world summit rais pt
thought blackston investor day top slide
note meet manag
color fundament focu call hc servic bx
updat tct
govern muster support mustard ga indic
fda approv duvelisib copiktra cll/sll fl ahead
interest updat gild/srpt/sndx
siriu xm acquir pandora billion move rate
analyst certif import disclosur see
barn announc definit agreement acquir gimat italy-bas leader advanc end-of-arm tool system industri
autom robot expect deal close octob gimat spend sale design
develop custom autom robot specif rang end applic market includ automot packag
healthcar food/beverag global sale network barn fund transact cash exist borrow capac
end debt/ebitda avail borrow capac repurchas share
author remain
emerg technolog servic
takeaway ole world summit rais pt
attend ole world summit san francisco last week came away increment posit regard
see multipl trend benefit incumb emitt materi supplier believ mobil market resum aggress adopt
display base design choic lead handset oem expect tv keep share gain momentum high-end
tv market next two three year believ upsid commerci blue emitt materi current
uncaptur street model remain intact rais price target base ep estim
cloud
announc yesterday close cfo sunit patel depart septemb mr patel join t-mobil lead s/tmu
merger integr effort expect weak stock tomorrow investor like concern synergi realiz
patel departur one best cfo ever work departur disappoint believ lvlt deep
manag bench jeff storey ceo continu drive forc behind restructur expens reduct remain
confid track margin synergi realiz though recogn percept like cap stock quarter
believ manag care group prime strong finish year group continu produc strong result gener
maintain outlook look forward concern around aggress commerci price appear warrant
compani continu believ competit major market remain ration back record-low cost-trend strong govern
enrol growth tailwind rise rate elimin hif believ group well posit build
recent success back half year
thought blackston investor day top slide
last friday new york bx host first investor day four year expect day focus firm achiev
past four year opportun futur growth importantli introduc firm senior busi head investor commun
struck us day bx franchis realli reward higher valuat four year despit showcas
busi substanti larger size scale outstand perform think bx made compel case higher
valuat usual practic highlight top slide insid continu recommend stock
note meet manag
last week chanc visit new york mid-atlant investor rmr cfo matthew jordan head ir timothi bonang
mani question surround four key theme growth initi gov/sir merger use cash balanc key risk
stock under-perform sinc gov/sir merger announc increment posit stock still
robust busi model perpetu manag agreement good pipelin growth initi option larg
pile cash zero debt
color fundament focu call hc servic bx
updat tct
provid sever updat transcathet cardiovascular tct symposium yesterday highlight includ
earlier expect fda approv eluvia drug-elut stent peripher arteri diseas previou target posit
data eluvia imperi trial steadi progress compani tavr program focu cerebr protect tavr manag
thought mitral valv treatment tailwind behind compani watchman devic
govern muster support mustard ga indic
mdwd announc receipt barda award fund develop nexobrid treatment sulfur mustard injuri mustard
ga burn like normal burn caus thermal burn skin injuri contract provid fund support pivot
studi anim fda anim rule eight-year contract also contain option addit fund
addit develop activ anim pivot studi bla submiss mdwd previous receiv barda contract potenti
total nexobrid fulli fund develop thermal burn see award support mustard ga indic
current includ model posit could provid addit upsid
fda approv duvelisib copiktra cll/sll fl ahead pdufa
approv duvelisib copiktra third-lin cll fl line expect anticip approv relapsed/
refractori set diseas earli octob includ sale copiktra duvelisib
like drug contribut modestli revenu due verastem readi detail distribut drug adjust
outlook drug launch better sens earli adopt pattern believ copiktra meaning add
armamentarium patient fail two prior therapi
interest updat gild/srpt/sndx
day full substanti news flow end approach compani enter quiet period interest updat
gilead sarepta syndax coverag list announc would offer brand gener
combin hcv medicin harvoni/epclusa ip us potenti deftli wrong-foot aggress price strategi
mavyret clinic hold lift aav gene therapi dmd potenti clear way hold import meet
regul next clinic develop step disclos phase pivot studi readout entinostat
breast cancer delay potenti creat addit nervous among investor
siriu xm acquir pandora billion move rate
move rate perform pandora announc definit agreement sell siriu xm all-stock tax-fre deal
approxim premium sharehold receiv fix exchang ratio newli issu stock share
agreement includ go-shop provis wherein board may activ seek altern propos believ
legal/procedur purpos given short length compani activ pursu bid month ago subject approv
transact expect close valuat materi discount ad-support internet compani reflect
challeng competit posit compani build competit stream music
behind report call switch digitim
dram bust busi usual ee time
samsung reportedli plan cut memori product ee time
sep fall summit focus spec pharma diseas new york ny -- today wednesday
